TY - JOUR
T1 - Differences in In-Hospital and Post-Discharge Ischemic Stroke Care According to Prestroke Functional Status
AU - Wechsler, Paul M.
AU - Mistry, Eva A.
AU - Sucharew, Heidi
AU - Robinson, David J.
AU - Stanton, Robert
AU - La Rosa, Felipe de los Rios
AU - Mackey, Jason
AU - Ferioli, Simona
AU - Demel, Stacie L.
AU - Coleman, Elisheva R.
AU - Jasne, Adam
AU - Slavin, Sabreena
AU - Walsh, Kyle B.
AU - Star, Michael
AU - Haverbusch, Mary
AU - Alwell, Kathleen
AU - Woo, Daniel
AU - Kleindorfer, Dawn O.
AU - Kissela, Brett M.
N1 - Publisher Copyright: © 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
PY - 2025
Y1 - 2025
N2 - BACKGROUND: Limited data exist regarding differences in ischemic stroke care across the care continuum between patients with and without prestroke disability. We investigated differences in in-hospital and postdischarge ischemic stroke cause evaluation and treatment between patients with and without prestroke disability using population-based data in the United States. METHODS: We ascertained all adult patients (≥18 years) hospitalized with acute ischemic stroke within the Greater Cincinnati/ Northern Kentucky population between January 1, 2015, and December 31, 2015. We used univariate analyses and logistic regression to compare differences in acute ischemic stroke reperfusion therapies, stroke cause evaluation, prescription of secondary stroke prevention treatments, and rehabilitation between patients with prestroke disability (modified Rankin Scale score ≥2) and those without prestroke disability (modified Rankin Scale score 0–1). RESULTS: Of 2476 ischemic stroke patients, 1326 (53%) had prestroke disability. Prestroke disability was associated with lower odds of receiving thrombolysis (adjusted odds ratio [aOR], 0.43 [95% CI, 0.28–0.68], P<0.01) and endovascular thrombectomy (aOR, 0.32 [95% CI, 0.13–0.78], P<0.01). Patients with prestroke disability were less likely to receive complete in-hospital stroke cause evaluation (aOR, 0.48 [95% CI, 0.33–0.69], P<0.01) and there were small differences in antiplatelet (84% versus 87%) and statin therapy (80% versus 86%) prescribed at discharge. Those with prestroke disability were more likely to receive in-hospital (aOR, 2.6 [95% CI, 2.11–3.21], P<0.01) and postdischarge rehabilitative therapies (aOR, 2.27 [95% CI, 1.86–2.77], P<0.01). CONCLUSION: Further research into factors driving medical decision-making for patients with prestroke disability is needed to optimize the entire spectrum of ischemic stroke care for this population.
AB - BACKGROUND: Limited data exist regarding differences in ischemic stroke care across the care continuum between patients with and without prestroke disability. We investigated differences in in-hospital and postdischarge ischemic stroke cause evaluation and treatment between patients with and without prestroke disability using population-based data in the United States. METHODS: We ascertained all adult patients (≥18 years) hospitalized with acute ischemic stroke within the Greater Cincinnati/ Northern Kentucky population between January 1, 2015, and December 31, 2015. We used univariate analyses and logistic regression to compare differences in acute ischemic stroke reperfusion therapies, stroke cause evaluation, prescription of secondary stroke prevention treatments, and rehabilitation between patients with prestroke disability (modified Rankin Scale score ≥2) and those without prestroke disability (modified Rankin Scale score 0–1). RESULTS: Of 2476 ischemic stroke patients, 1326 (53%) had prestroke disability. Prestroke disability was associated with lower odds of receiving thrombolysis (adjusted odds ratio [aOR], 0.43 [95% CI, 0.28–0.68], P<0.01) and endovascular thrombectomy (aOR, 0.32 [95% CI, 0.13–0.78], P<0.01). Patients with prestroke disability were less likely to receive complete in-hospital stroke cause evaluation (aOR, 0.48 [95% CI, 0.33–0.69], P<0.01) and there were small differences in antiplatelet (84% versus 87%) and statin therapy (80% versus 86%) prescribed at discharge. Those with prestroke disability were more likely to receive in-hospital (aOR, 2.6 [95% CI, 2.11–3.21], P<0.01) and postdischarge rehabilitative therapies (aOR, 2.27 [95% CI, 1.86–2.77], P<0.01). CONCLUSION: Further research into factors driving medical decision-making for patients with prestroke disability is needed to optimize the entire spectrum of ischemic stroke care for this population.
KW - disability
KW - ischemic stroke
KW - prevention
UR - https://www.scopus.com/pages/publications/105008126059
U2 - 10.1161/JAHA.124.040499
DO - 10.1161/JAHA.124.040499
M3 - Article
C2 - 40417811
SN - 2047-9980
VL - 14
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 11
M1 - e040499
ER -